April 22 (Reuters) - Tokuyama Corp 4043.T:
TOKUYAMA CORP: NOTICE CONCERNING ACQUISITION OF A NEWLY ESTABLISHED COMPANY THAT WILL SUCCEED JSR'S IN VITRO DIAGNOSTIC PHARMACEUTICAL BUSINESS
TOKUYAMA CORP: TO ACQUIRE IN VITRO DIAGNOSTICS AND IN VITRO DIAGNOSTIC PHARMACEUTICAL MATERIALS BUSINESSES HELD BY JSR FOR 82 BILLION YEN
TOKUYAMA CORP: ANY IMPACT OF ACQUISITION OF SHARES ON TOKUYAMA'S CONSOLIDATED FINANCIAL RESULTS FOR FISCAL YEAR ENDING MARCH 31, 2026, IS CURRENTLY BEING ASSESSED
Source text: ID:nTSpv7ea8b
Further company coverage: 4043.T
(Reporting by Tokyo Newsroom)
((+81345201189;))